TriaGen Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-20,392
Closed -$1.74M 172
2021
Q4
$1.74M Sell
20,392
-348
-2% -$27.2K 0.86% 43
2021
Q3
$1.57M Hold
20,740
0.85% 41
2021
Q2
$1.65M Sell
20,740
-391
-2% -$32K 0.85% 39
2021
Q1
$1.67M Sell
21,131
-96
-0.5% -$7.53K 0.96% 40
2020
Q4
$1.81M Buy
+21,227
New +$1.76M 1.06% 29

Other funds holding CL

TriaGen Wealth Management's CL Position: Q1 2022 in Review

TriaGen Wealth Management sold out of Colgate-Palmolive (CL) in Q1 2022, closing a stake of 20,392 shares — an estimated $1.74M sold.

TriaGen Wealth Management first reported a position in CL in Q4 2020 and held it in 5 quarters. The position peaked at $1.81M in Q4 2020. 1,632 funds tracked by Wall St. Rank hold CL as of Q1 2022.

  • TriaGen Wealth Management reported no remaining Colgate-Palmolive position as of Q1 2022 after selling out during the quarter.
  • TriaGen Wealth Management sold 20,392 Colgate-Palmolive shares in Q1 2022, an estimated $1.74M.
  • TriaGen Wealth Management first reported a position in Colgate-Palmolive in Q4 2020 and held it in 5 quarters.
  • TriaGen Wealth Management's Colgate-Palmolive position peaked at $1.81M in Q4 2020.
  • 1,632 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2022.

Based on TriaGen Wealth Management's 13F filing for Q1 2022, filed 29 Apr 2022.